Past Events

Oct 8 – Oct 12, 2024

29th Annual Congress of the World Muscle Society (WMS 2024)

Sep 24, 2024 8:30 am EDT

Duchenne Muscular Dystrophy Program Update

Sep 18, 2024 8:35 am EDT

2024 Cantor Fitzgerald’s Global Healthcare Conference

Sep 17 – Sep 19, 2024

6th Annual Exosome-Based Therapeutic Summit

Sep 9, 2024 2:00 pm EDT

H.C. Wainwright 26th Annual Global Investment Conference

Aug 7, 2024 4:30 pm EDT

Capricor Therapeutics Second Quarter 2024 Financial Results and Corporate Update Conference Call

Jun 27 – Jun 29, 2024

Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference

May 29 – Jun 1, 2024

International Society for Cell & Gene Therapy (ISCT) 2024 Meeting

May 23 – May 26, 2024

CureDuchenne 2024 FUTURES National Conference

May 14, 2024 10:00 am PDT

2024 Annual Meeting of Stockholders

May 13, 2024 4:30 pm EDT

Capricor Therapeutics First Quarter 2024 Financial Results and Corporate Update Conference Call

May 9, 2024

Parent Project Muscular Dystrophy (PPMD) Cardiac Workshop III

May 9 – May 12, 2024

International Society of Extracellular Vesicles (ISEV) 2024 Meeting

May 7 – May 11, 2024

American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

Apr 29, 2024 8:30 am EDT

CAP-1002 DMD Program Update Call

Apr 3, 2024 1:30 pm EDT

Cantor Fitzgerald’s Muscular Dystrophy Symposium

Mar 26, 2024 2:00 pm EDT

H.C. Wainwright 2nd Annual Cell Therapy Conference

Mar 6, 2024 11:45 am EDT – 12:00 pm EDT

2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Feb 29, 2024 4:30 pm EDT

Capricor Therapeutics Fourth Quarter 2023 Financial Results and Corporate Update Conference Call

Nov 14, 2023 4:30 pm EDT

Capricor Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call

Oct 25, 2023

CAP-1002 HOPE-3 Program Update (Webinar Recording)

Sep 29, 2023 8:30 am EDT

FDA Type-B Meeting Update Call

Aug 7, 2023 4:30 pm EDT

Capricor Therapeutic Second Quarter 2023 Financial Results and Corporate Update Conference Call

Jun 30, 2023 10:45 am CDT

Parent Project Muscular Dystrophy (PPMD) Annual Conference

Jun 12, 2023 10:00 am PDT

Annual Meeting of Stockholders

May 11, 2023 4:30 pm EDT

Capricor Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call

Mar 15, 2023 4:30 pm EDT

Capricor Therapeutics Fourth Quarter 2022 Financial Results and Corporate Update Conference Call

Jan 25, 2023 1:00 pm EDT

PPMD Webinar

Nov 10, 2022

Capricor Therapeutics Third Quarter 2022 Financial Results and Corporate Update Conference Call

Oct 14, 2022

One-Year Results from HOPE-2 Open Label Extension Study Presented at World Muscle Society 2022 – Nova Scotia, Canada

Sep 13, 2022

Capricor’s Presentation at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 10, 2022

Capricor Therapeutics Second Quarter 2022 Financial Results and Corporate Update Conference Call

Jun 27, 2022

Capricor HOPE-2 OLE Data

Oct 22, 2021

Webcast with BioPub Research

Sep 24, 2021

HOPE-2 – One Year Results Data Call

Jun 22, 2021

Capricor Therapeutics Presentation at Parent Project Muscular Dystrophy (PPMD) 2021 Virtual Annual Conference

May 29, 2021

White House Chronicle, “Hurdles for innovative drug development at small biotech companies” featuring Capricor’s, CEO, Linda Marbàn

May 18, 2021

Capricor Presentation at 10th Annual ISEV Virtual Meeting 2021

Aug 5, 2020

White House Chronicle, “Developing exosomal therapies for diseases” featuring Capricor’s ,CEO, Linda Marbàn

Jul 30, 2020

CEO Spotlight Call: Exosomes Panel, Hosted by LifeSci Advisors

Jun 16, 2020

The Big Biz Show: Interview

Apr 17, 2020

Webcast with BioPub Research

Apr 15, 2020

KOL Call on Cardiac Complications of Duchenne Muscular Dystrophy (DMD)

Mar 26, 2020